| Company/Division name | Ocugen, Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | Outsourced |
| City reshored to: | Malvern |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, biopharmaceutical |
| Product(s) reshored | biopharmaceuticals, COVAXIN™, COVID-19 vaccine |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training, Other, import replacement, Covid-19 |
